U.S. markets closed
  • S&P 500

    4,538.43
    -38.67 (-0.84%)
     
  • Dow 30

    34,580.08
    -59.72 (-0.17%)
     
  • Nasdaq

    15,085.47
    -295.85 (-1.92%)
     
  • Russell 2000

    2,159.31
    -47.02 (-2.13%)
     
  • Crude Oil

    66.22
    -0.28 (-0.42%)
     
  • Gold

    1,782.10
    +21.40 (+1.22%)
     
  • Silver

    22.45
    +0.17 (+0.76%)
     
  • EUR/USD

    1.1317
    +0.0012 (+0.10%)
     
  • 10-Yr Bond

    1.3430
    -0.1050 (-7.25%)
     
  • GBP/USD

    1.3235
    -0.0067 (-0.50%)
     
  • USD/JPY

    112.8000
    -0.4090 (-0.36%)
     
  • BTC-USD

    49,325.29
    +882.06 (+1.82%)
     
  • CMC Crypto 200

    1,367.14
    -74.62 (-5.18%)
     
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • Nikkei 225

    28,029.57
    +276.20 (+1.00%)
     

Cryo-cell International Inc (CCEL) Chairman, Co-CEO David Portnoy Bought $77,098 of Shares

·1 min read

- By insider

Chairman, Co-CEO of Cryo-cell International Inc (30-Year Financial, Insider Trades) David Portnoy (insider trades) bought 9,897 shares of CCEL on 10/26/2020 at an average price of $7.79 a share. The total cost of this purchase was $77,098.


Cryo-Cell International Inc is engaged in cellular processing & cryogenic storage. Its services include umbilical cord blood banking, umbilical cord tissue banking and umbilical cord blood and tissue banking prices. Cryo-Cell International Inc has a market cap of $58.330 million; its shares were traded at around $7.73 with a P/E ratio of 19.33 and P/S ratio of 2.00. GuruFocus has detected 3 severe warning signs with Cryo-Cell International Inc. .

CEO Recent Trades:

  • Chairman, Co-CEO David Portnoy bought 9,897 shares of CCEL stock on 10/26/2020 at the average price of $7.79. The price of the stock has decreased by 0.77% since.

  • Chairman, Co-CEO David Portnoy bought 2,000 shares of CCEL stock on 10/19/2020 at the average price of $6.94. The price of the stock has increased by 11.38% since.

For the complete insider trading history of CCEL, click here

.This article first appeared on GuruFocus.